We are live on ! Find out more
CODX

Co-Diagnostics

35 hedge funds and large institutions have $1.44M invested in Co-Diagnostics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

0.07% less ownership

Funds ownership: 0.58%0.51% (-0.07%)

8% less funds holding

Funds holding: 3835 (-3)

20% less capital invested

Capital invested by funds: $1.81M → $1.44M (-$368K)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
35
Holders Change
-3
Holders Change %
-7.89%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
9
Reduced
8
Closed
7
Calls
$18K
Puts
Net Calls
+$18K
Net Calls Change
+$15K

CODX Hedge Fund Activity: Q2 2025 in Review

35 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q2 2025, worth a combined $1.44M — down 20% from $1.81M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CODX and 4 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 9 added.

The largest buyer was Jane Street, adding an estimated $39.3K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $84.5K sold.

  • 35 institutional investors held Co-Diagnostics (CODX) as of Q2 2025, down from 38 in Q1 2025.
  • Funds reported $1.44M of Co-Diagnostics stock for Q2 2025, down 20% quarter-over-quarter.
  • 4 funds opened new Co-Diagnostics positions in Q2 2025 and 7 closed out, a net change of -3 holders.
  • The largest Co-Diagnostics buyer in Q2 2025 was Jane Street, an estimated $39.3K added.
  • The largest Co-Diagnostics seller in Q2 2025 was Bridgeway Capital Management, an estimated $84.5K sold.

Based on aggregated 13F filings for Q2 2025.